HIV-1 V3 loop crown epitope-focused mimotope selection by patient serum from random phage display libraries: Implications for the epitope structural features-Reference-Cited by-同舟云学术

HIV-1 V3 loop crown epitope-focused mimotope selection by patient serum from random phage display libraries: Implications for the epitope structural features

Published:2013-06 Issue:2 Volume:54 Page:148-156
ISSN:0161-5890
Container-title:Molecular Immunology
language:en
Short-container-title:Molecular Immunology

Author:

Gazarian Karlen G.,Palacios-Rodríguez Yadira,Gazarian Tatiana G.,Huerta Leonor

Funder

Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México

Publisher

Elsevier BV

Subject

Molecular Biology,Immunology

Reference64 articles.

1. Resistance of subtype C HIV-1 strains to anti-V3 loop antibodies;Almond;Advances in Virology,2012

2. Structure of antibody F425-B4e8 in complex with a V3 peptide reveals a new binding mode for HIV-1 neutralization;Bell;Journal of Molecular Biology,2008

3. Comprehensive cross-clade neutralization of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies;Binley;Journal of Virology,2004

4. Structural basis of the cross-reactivity of genetically related human anti-HIV-1 mAbs: implications for design of V3-based immunogens;Burke;Structure,2009

5. Molecular determinants of acute single cell lysis by human immunodeficiency virus type 1;Cao;Journal of Virology,1996

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epitopes and Mimotopes Identification Using Phage Display for Vaccine Development against Infectious Pathogens;Vaccines;2023-06-29

2. Filamentous bacteriophages, natural nanoparticles, for viral vaccine strategies;Nanoscale;2022

3. Global Variability of V3 Loop Tetrapeptide Motif: a Concern for HIV-1 Neutralizing Antibodies-based Vaccine Design and Antiretroviral Therapy;Journal of Medical Microbiology and Infectious Diseases;2021-09-01

4. Effective Delivery of Nef-MPER-V3 Fusion Protein Using LDP12 Cell Penetrating Peptide for Development of Preventive/Therapeutic HIV-1 Vaccine;Protein & Peptide Letters;2020-11-16

5. The development of inovirus-associated vector vaccines using phage-display technologies;Expert Review of Vaccines;2019-09-02